Question:

When can both flow cytometry and immunohistochemistry (IHC) be reported together with modifier 59 or XU?

Answer:

Generally, not reimbursed for testing when duplicate testing is performed on the same or similar specimens. The diagnosis should be established using one of these methods. However, a payer may reimburse both procedures if both methods are required because the initial method does not explain all initial findings based on light microscopic examination. If the need for both methods is documented in the medical record, the provider may report both – flow cytometry and IHC – by using modifier 59 or XU.

This question was answered in our annual Laboratory Coding Update webcast. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.

Facebook
Twitter
LinkedIn

CPT® copyright 2025 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24